anti-CD3 bispecific T-cell engager (Dong-A/ABL Bio)

N/A

Report date: 2026/03/19 16:58:17

Base Information

Drug Nameanti-CD3 bispecific T-cell engager (Dong-A/ABL Bio)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbl Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbl Bio IncDong-A ST Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A